The effect of metformin in different phenotypes of poly cystic ovary syndrome according to Rotterdam criteria criteria
Phase 2
- Conditions
- poly cystic ovary syndrome.PCOD ( poly cystic ovary syndrome)
- Registration Number
- IRCT201103146063N1
- Lead Sponsor
- Tehran University of Medical Science and Health Service
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 290
Inclusion Criteria
Infertile women were included in the patients attending the outpatient clinic of the Infertility Research Centre of Shariati Hospital. The diagnosis of PCOD was based on the Rotterdam criteria, age between 18 to35 years, normal thyroid, liver and kidney, normal sperm count according to WHO criteria, taking no metformin in previous 8 weeks, normal hysterosalpingography
Exclusion criteria: mullerian anomaly, abnormal sperm count, thyroid, liver or kidney dysfunction
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy rate. Timepoint: three months and half after starting the treatment. Method of measurement: trans vaginal sonography.;Ovulation rate. Timepoint: two months and half after starting the treatment. Method of measurement: transvaginal sonography.
- Secondary Outcome Measures
Name Time Method